title: Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
abstract: BACKGROUND
  Pregnancy associated with primary pulmonary hypertension is an uncommon observation, with maternal mortality > 50%. Experience treating this condition is limited. Past reports have emphasized the need for pregnancy termination. In the last few years there has been considerable interest in long-term intravenous use of epoprostenol (prostacyclin) in patients with primary pulmonary hypertension.
  
  
  METHODS
  A woman with severe primary pulmonary hypertension who was on long-term epoprostenol therapy became pregnant with twins and was treated with high doses of epoprostenol and nitric oxide during delivery and the postpartum period. She was well six months later on continuous epoprostenol therapy. The one viable infant was alive and still hospitalized at this writing.
  
  
  CONCLUSIONS
  Epoprostenol therapy may be continued during pregnancy in patients with severe primary pulmonary hypertension for long-term pulmonary vasodilatation.
authors.affiliation: Department of Obstetrics and Gynecology, State University of New York Health Sciences Center at Syracuse 13210, USA.
authors.forename: S S
authors.initials: SS
authors.lastname: Badalian
authors.forename: R K
authors.initials: RK
authors.lastname: Silverman
authors.forename: R H
authors.initials: RH
authors.lastname: Aubry
authors.forename: J
authors.initials: J
authors.lastname: Longo
mesh_terms: D000014:Abnormalities, Drug-Induced; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D005145:Face / Q000002:abnormalities; D005260:Female; D006801:Humans; D006849:Hydrocephalus / Q000139:chemically induced*; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy*; D009569:Nitric Oxide / Q000627:therapeutic use*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D013577:Syndrome; D014427:Twins; D014859:Warfarin / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D009569:Nitric Oxide; D014859:Warfarin; D011464:Epoprostenol